name:-0.059083938598633
name:-0.054404973983765
name:-0.0010421276092529
Alcon Manufacturing, Ltd. Patent Filings

Alcon Manufacturing, Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Alcon Manufacturing, Ltd..The latest application filed is for "rnai-mediated inhibition of aquaporin 4 for treatment of iop-related conditions".

Company Profile
0.52.48
  • Alcon Manufacturing, Ltd. - Fort Worth TX
  • ALCON MANUFACTURING, LTD. - Forth Worth TX
  • Alcon Manufacturing, Ltd. -
  • ALCON MANUFACTURING, LTD. - 6201 South Freeway TB4-8 Fort Worth TX
  • Alcon Manufacturing Ltd. - 6201 South Freeway IP Legal Mail Code TB4-8 Fort Worth TX
  • ALCON MANUFACTURING, LTD. - 6201 South Freeway Mail Code TB4-8 Fort Worth TX
  • ALCON MANUFACTURING, LTD. - 6201 South Freeway Fort Worth TX
  • Alcon Manufacturing Ltd.. - Ft. Worth JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Pseudo-accommodative IOL having diffractive zones with varying areas
Grant 7,441,894 - Zhang , et al. October 28, 2
2008-10-28
RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS
App 20080214486 - Chatterton; Jon E. ;   et al.
2008-09-04
Substantially Pure Fluorescein
App 20080176930 - Bydlinski; Gregory ;   et al.
2008-07-24
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
App 20080171719 - Chatterton; Jon E. ;   et al.
2008-07-17
Video overlay system for surgical apparatus
Grant 7,400,752 - Zacharias July 15, 2
2008-07-15
Inhibitors Of Protein Kinase C-delta For The Treatment Of Glaucoma
App 20080153903 - FLEENOR; Debra L. ;   et al.
2008-06-26
6-AMINOIMIDAZO[1,2-b]PYRIDAZINE ANALOGS AS RHO KINASE INHIBITORS FOR THE TREATMENT OF RHO KINASE-MEDIATED DISEASES AND CONDITIONS
App 20080153813 - CHEN; Hwang-Hsing ;   et al.
2008-06-26
Devices And Methods For Ophthalmic Drug Delivery
App 20080145406 - Asgharian; Bahram ;   et al.
2008-06-19
Use Of Connective Tissue Mast Cell Stabilizers To Facilitate Ocular Surface Re-epithelization And Wound Repair
App 20080139531 - Yanni; John M. ;   et al.
2008-06-12
Use of PEO-PBO block copolymers in ophthalmic compositions
App 20080138310 - Ketelson; Howard Allen ;   et al.
2008-06-12
Modulation Of Polysialylated Neural Adhesion Molecules (psa-ncam) As A Regulator Of Ocular Disease
App 20080132451 - Gadd; Martha E. ;   et al.
2008-06-05
Ophthalmic injection system
App 20080125712 - Dacquay; Bruno ;   et al.
2008-05-29
Punctal Plug Comprising A Water-insoluble Polymeric Matrix
App 20080114076 - Asgharian; Bahram ;   et al.
2008-05-15
Water Insoluble Polymer Matrix For Drug Delivery
App 20080113027 - Asgharian; Bahram ;   et al.
2008-05-15
Method of Treating Asthma, Allergic Rhinitis, and Skin Disorders
App 20080108695 - Klimko; Peter G. ;   et al.
2008-05-08
Pai-1 Binding Modulators For The Treatment Of Ocular Disorders
App 20080107644 - FLEENOR; Debra L. ;   et al.
2008-05-08
2-pyrrolidone Derivatives For Preservation Of Ophthalmic, Otic And Nasal Compositions
App 20080095863 - Kabra; Bhagwati P.
2008-04-24
Packaging Materials For Formulations Containing 2-pyrrolidone Derivatives
App 20080093247 - Han; Wesley Wehsin ;   et al.
2008-04-24
Spring actuated delivery system
App 20080097390 - Dacquay; Bruno ;   et al.
2008-04-24
Method of delivering temperature controlled intraocular lens
App 20080097461 - Boukhny; Mikhail ;   et al.
2008-04-24
Intraocular lens delivery system with temperature control
App 20080097460 - Boukhny; Mikhail ;   et al.
2008-04-24
Ophthalmic injection method
App 20080097379 - Dacquay; Bruno ;   et al.
2008-04-24
Intraocular Lenses With Unique Blue-violet Cutoff And Blue Light Transmission Characteristics
App 20080090937 - Jinkerson; David L. ;   et al.
2008-04-17
Superoxide Dismutase-2 Expression And Modulation For Glaucoma Diagnosis And Therapy
App 20080085878 - WANG; Wan-Heng ;   et al.
2008-04-10
Self Preserved Aqueous Pharmaceutical Compositions
App 20080075790 - Kabra; Bhagwati P. ;   et al.
2008-03-27
Antagonists Of Ci-m6p/igf2r For Prevention And Treatment Of Ctgf-mediated Ocular Disorders
App 20080057072 - SHEPARD; Allan R. ;   et al.
2008-03-06
Rnai-mediated Inhibition Of Gremlin For Treatment Of Iop-related Conditions
App 20080051361 - Chatterton; Jon E. ;   et al.
2008-02-28
Apodized diffractive IOL with frustrated diffractive region
App 20080030677 - Simpson; Michael J.
2008-02-07
Process For Preparing Pyranoindazole Serotonergic Receptor Agonists
App 20080033183 - CONROW; Raymond E.
2008-02-07
Intermediates And Methods For Serotonergic Agonist Synthesis
App 20080033184 - Delgado; Pete ;   et al.
2008-02-07
Antagonists Of Endothelial Differentiation Gene Subfamily 3 (edg-3, S1p3) Receptors For Prevention And Treatment Of Ocular Disorders
App 20080025973 - FLEENOR; Debra L. ;   et al.
2008-01-31
Low-tack Ophthalmic And Otorhinolaryngological Device Materials
App 20080021129 - Cordova; Diana M. ;   et al.
2008-01-24
Low-tack Ophthalmic And Otorhinolaryngological Device Materials
App 20080021548 - Cordova; Diana M. ;   et al.
2008-01-24
Aryl And Heteroaryl Tetrahydrobenzazepine Derivatives And Their Use For Treating Glaucoma
App 20070293475 - Mohapatra; Suchismita ;   et al.
2007-12-20
Rnai-mediated Inhibition Of Tumor Necrosis Factor Alpha-related Conditions
App 20070281901 - Yanni; John M. ;   et al.
2007-12-06
RNAi-MEDIATED INHIBITION OF IGF1R FOR TREATMENT OF OCULAR ANGIOGENESIS
App 20070275922 - Chatterton; Jon E. ;   et al.
2007-11-29
Correction of higher order aberrations in intraocular lenses
App 20070268453 - Hong; Xin ;   et al.
2007-11-22
Serotonergic 5HT.sub.7 receptor compounds for treating ocular and CNS disorders
Grant 7,285,553 - May , et al. October 23, 2
2007-10-23
Prenyltransferase Inhibitors For Ocular Hypertension Control And The Treatment Of Glaucoma
App 20070232675 - Shepard; Allan R. ;   et al.
2007-10-04
Method Of Treating Glaucoma
App 20070203174 - KLIMKO; Peter G. ;   et al.
2007-08-30
Pseudo-accommodative IOL having diffractive zones with varying areas
App 20070182921 - Zhang; Xiaoxiao ;   et al.
2007-08-09
Intra-ocular device with multiple focusing powers/optics
App 20070182917 - Zhang; Xiaoxiao ;   et al.
2007-08-09
Pseudo-accommodative IOL having multiple diffractive patterns
App 20070182924 - Hong; Xin ;   et al.
2007-08-09
Posterior chamber phakic intraocular lens
App 20070168028 - Tran; Son Trung ;   et al.
2007-07-19
RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis
App 20070155690 - Chatterton; Jon E. ;   et al.
2007-07-05
(indazol-5-yl)-pyrazines And (1,3-dihydro-indol-2-one)-pyrazines For Treating Rho Kinase-mediated Diseases And Conditions
App 20070149548 - Hellberg; Mark R. ;   et al.
2007-06-28
C3-Convertase Inhibitors for the Prevention and Treatment of Age-Related Macular Degeneration in Patients With At Risk Variants Of Complement Factor H
App 20070149616 - Clark; Abbot F. ;   et al.
2007-06-28
RNAi-mediated inhibition of RHO kinase for treatment of ocular disorders
App 20070149473 - Chatterton; Jon E. ;   et al.
2007-06-28
Composition And Methods For Inhibiting The Progression Macular Degeneration And Promoting Healthy Vision
App 20070141170 - LANG; JOHN C.
2007-06-21
Methods for diagnosing glaucoma and discovering anti-glaucoma drugs
Grant 7,220,546 - Clark , et al. May 22, 2
2007-05-22
Maintaining preoperative position of the posterior lens capsule after cataract surgery
App 20070093892 - Mackool; Richard J.
2007-04-26
Ophthalmic compositions containing galactomannan polymers and borate
Grant 7,169,767 - Asgharian January 30, 2
2007-01-30
Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders
App 20060275797 - Shepard; Allan R. ;   et al.
2006-12-07
Serotonergic 5HT.sub.7 receptor compounds for treating ocular and CNS disorders
Grant 7,060,704 - May , et al. June 13, 2
2006-06-13
Use of low molecular weight amino alcohols in ophthalmic compositions
Grant 7,045,095 - Asgharian May 16, 2
2006-05-16
Use of AP-1 activators to treat glaucoma and ocular hypertension
Grant 7,005,446 - Shade , et al. February 28, 2
2006-02-28
Serotonergic 5HT.sub.7 receptor compounds for treating ocular and CNS disorders
Grant 6,960,579 - May , et al. November 1, 2
2005-11-01
Use of low molecular weight amino alcohols in ophthalmic compositions
Grant 6,949,218 - Asgharian September 27, 2
2005-09-27
Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions
Grant 6,916,958 - Park , et al. July 12, 2
2005-07-12
Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
Grant 6,906,077 - Pang June 14, 2
2005-06-14
Surgical handpiece
Grant 6,860,868 - Sussman , et al. March 1, 2
2005-03-01
Use of borate-polyol complexes in ophthalmic compositions
Grant 6,849,253 - Chowhan , et al. February 1, 2
2005-02-01
Ophthalmic compositions containing galactomannan polymers and borate
Grant 6,838,449 - Asgharian January 4, 2
2005-01-04
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
Grant 6,723,748 - Klimko , et al. April 20, 2
2004-04-20
15-fluoro prostaglandins as ocular hypotensives
Grant 6,680,339 - Klimko , et al. January 20, 2
2004-01-20
Pumping chamber for a liquefracture handpiece
Grant 6,676,628 - Sussman , et al. January 13, 2
2004-01-13
Serotonergic 5ht2 agonists for treating glaucoma
Grant 6,664,286 - May , et al. December 16, 2
2003-12-16
Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions
Grant 6,664,294 - Park , et al. December 16, 2
2003-12-16
Method of operating a liquefracture handpiece
Grant 6,648,847 - Sussman , et al. November 18, 2
2003-11-18
11.beta.-fluoro 15.beta.-hydroxy PGF2.alpha. analogs as FP receptor antagonists
Grant 6,649,655 - Sharif , et al. November 18, 2
2003-11-18
15-fluoro prostaglandins as ocular hypotensives
Grant 6,649,653 - Klimko , et al. November 18, 2
2003-11-18
Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
Grant 6,646,001 - Hellberg , et al. November 11, 2
2003-11-11
Method of operating a liquefracture handpiece
Grant 6,589,204 - Sussman , et al. July 8, 2
2003-07-08
Liquefracture handpiece tip
Grant 6,579,270 - Sussman , et al. June 17, 2
2003-06-17
Pumping chamber for a liquefaction handpiece
Grant 6,575,929 - Sussman , et al. June 10, 2
2003-06-10
Method of making high refractive index ophthalmic device materials
Grant 6,541,572 - LeBoeuf April 1, 2
2003-04-01
Compositions and methods for treating otic, ophthalmic and nasal infections
Grant 6,509,327 - Cagle , et al. January 21, 2
2003-01-21
Use of borate-polyol complexes in ophthalmic compositions
Grant 6,503,497 - Chowhan , et al. January 7, 2
2003-01-07
Non-peptide bradykinin receptor antagonists for use in controlling intraocular pressure and treating glaucoma
Grant 6,500,831 - Sharif December 31, 2
2002-12-31
Toric intraocular lens material
Grant 6,491,721 - Freeman , et al. December 10, 2
2002-12-10
Infusion control system
Grant 6,491,661 - Boukhny , et al. December 10, 2
2002-12-10
11-deoxy-16-fluoro-PGF2.alpha. analogs as FP receptor antagonists
Grant 6,492,417 - Sharif , et al. December 10, 2
2002-12-10
Ophthalmic compositions containing galactomannan polymers and borate
Grant 6,486,138 - Asgharian , et al. November 26, 2
2002-11-26
Prostaglandin E receptor agonists for treatment of dry eye
Grant 6,462,080 - Klimko October 8, 2
2002-10-08
Combination therapy for treating glaucoma
Grant 6,441,047 - DeSantis, Jr. August 27, 2
2002-08-27
Punctal cannula
Grant 6,428,502 - Lang August 6, 2
2002-08-06
Topical ophthalmic mast cell stabilizers for treating allergic eye disease
Grant 6,420,399 - Graff , et al. July 16, 2
2002-07-16
Ophthalmic compositions containing galactomannan polymers and borate
Grant 6,403,609 - Asgharian June 11, 2
2002-06-11
Liquefracture handpiece tip
Grant 6,398,759 - Sussman , et al. June 4, 2
2002-06-04
Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
Grant 6,395,746 - Cagle , et al. May 28, 2
2002-05-28
Upregulation of endogenous prostaglandins to lower intraocular pressure
Grant 6,376,541 - Nixon , et al. April 23, 2
2002-04-23
High refractive index ophthalmic device materials
Grant 6,353,069 - Freeman , et al. March 5, 2
2002-03-05
Prostaglandin e agonists for treatment of dry eye
Grant 6,344,477 - Sharif February 5, 2
2002-02-05
Use of low molecular weight amino alcohols in ophthalmic compositions
Grant 6,319,464 - Asgharian November 20, 2
2001-11-20
Brinzolamide and brimonidine for treating glaucoma
Grant 6,316,441 - Dean , et al. November 13, 2
2001-11-13
Method of controlling a liquefracture handpiece
Grant 6,315,755 - Sussman November 13, 2
2001-11-13
High refractive index ophthalmic device materials prepared using a post-polymerization cross-linking method
Grant 6,313,187 - LeBoeuf , et al. November 6, 2
2001-11-06
Simultaneous injection and aspiration of viscous fluids in a surgical system
Grant 6,290,690 - Huculak , et al. September 18, 2
2001-09-18
Method of cleaning contact lenses using carbon dioxide and carbonic acid
Grant 6,273,960 - Bhatia , et al. August 14, 2
2001-08-14
Gelling ophthalmic compositions containing xanthan gum
Grant 6,261,547 - Bawa , et al. July 17, 2
2001-07-17
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed